Publications - 'R'

Publications 1001 - 1025 de 1476
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
Results of Orthopaedic Surgery in Children with X-Linked Hypophosphatemic Rickets (XLHR)
A. Gizard; A. Rothenbuhler; Z. Pejin; G. Finidori; C. Glorion; B. de Billy; A. Linglart; P. Wicart
2016
Results of Orthopaedic Surgery in Children with X-Linked Hypophosphatemic Rickets (XLHR)
A. Gizard; A. Rothenbuhler; Z. Pejin; G. Finidori; C. Glorion; B. de Billy; A. Linglart; P. Wicart
2016
Results of PONDx, a prospective multicenter study of the Oncotype DX (R) breast cancer assay: Real-life utilization and decision impact in French clinical practice
E. Curtit; J.M. Vannetzel; J.C. Darmon; S. Roche; H. Bourgeois; S. Dewas; S. Catala; E. Mereb; C.Furtos Fanget; D. Genet; A.M. Forest; C. Bernier; X. Pivot
2019 		10.1016/j.breast.2018.12.015
Results of randomized, placebo (PL)-controlled phase II study evaluating efficacy and safety of regorafenib (REG) in patients (pts) with metastatic osteosarcoma (metOS), on behalf of the French Sarcoma Group (FSG) and Unicancer.
F. Duffaud; J.Y. Blay; O. Mir; P. Boudou-Rouquette; S. Piperno-Neumann; N. Penel; E. Bompas; C. Delcambre; E. Kalbacher; A. Italiano; O. Collard; C. Chevreau; A. Thyss; N. Isambert; J. Delaye; N.De Sousa Carvalho; C. Schiffler; C. Bouvier; V. Vidal; S. Chabaud
2018 		10.1200/JCO.2018.36.15_suppl.11504
Results of successive EORTC-CLG 58 881 and 58 951 trials in paediatric T-cell acute lymphoblastic leukaemia (ALL)
M. Hofmans; S. Suciu; A. Ferster; P. Van Vlierberghe; F. Mazingue; N. Sirvent; V. Costa; K. Yakouben; C. Paillard; A. Uyttebroeck; D. Plantaz; G. Plat; P. Simon; F. Millot; M. Poiree; J.Van der We Bosch; C. Piette; O. Minckes; P. Rohrlich; S. Girard; H. Cave; Y. Bertrand; B. De Moerloose
2019 		10.1111/bjh.15983
Results of the 2013 national ranking in France
D. Jolly; P. Ambrosi; P. Chaffanjon; D. Dreyfuss; C. Le Jeunne; G. Lorette; L. Obert; O. Palombi; J.P. Romanet
2014 		10.1016/j.lpm.2013.10.008
Results of the 2014 National Ranking in France
D. Jolly; P. Ambrosi; P. Chaffanjon; D. Dreyfuss; C. Le Jeunne; G. Lorette; L. Obert; O. Palombi; J.P. Romanet
2015 		10.1016/j.lpm.2014.11.008
Results of the 2015 national ranking in France
D. Jolly; P. Ambrosi; P. Chaffanjon; D. Dreyfuss; C. Le Jeunne; G. Lorette; L. Obert; O. Palombi; J.P. Romanet
2016 		10.1016/j.lpm.2015.09.025
Results of the Ebmt Saawp Phase III Prospective Randomized Multicenter Race Study of Horse Atg and Ciclosporin with or Without Eltrombopag in Naive Saa Patients
R.Peffault de Latour; J. Marsh; S. Iacobelli; S. Terwel; A. Hill; C.J.M. Halkes; C. Recher; F. Barraco; E. Forcade; J.Carlos Val Llamas; B. Dresler; J.Baptiste Mear; M.Teresa Van Lint; R.A.P. Raymakers; M.R. De Groot; E. Daguindau; E. Nur; W. Barcellini; N.H. Russell; L. Terriou; A.Paola Iori; I. Sanchez-Ortega; B. Xicoy; I. Jarque; J. Cavenagh; F.Sicre de Fontbrune; A. Kulasekararaj; S. Marotta; T. Munir; J.M.L. Tjon; S. Tavitian; A. Praire; L. Clement; F. Rabian; A.E. Smith; R. Cook; L. Marano; M. Griffin; E. Palmisani; P. Muus; F. Cacace; J.R. Passweg; G. Socie; G.J. Mufti; C. Dufour; A. Risitano
2020
Results of the French National REPERE Survey regarding Pancreatic Cancer Patients' Care
F. Bonnetain; M. de Bausset; P. Hammel; G. Lledo; S. Obled; M. Ychou
2016
Results of the French National REPERE Survey regarding Pancreatic Cancer Patients' Care
F. Bonnetain; M. de Bausset; P. Hammel; G. Lledo; S. Obled; M. Ychou
2016
Results of the LMS03 phase II study evaluating gemcitabine combined with pazopanib as a 2nd-line treatment for metastatic/relapsed leiomyosarcomas (uterine or soft tissue) after failure of anthracycline-based chemotherapy: The UNICANCER SARCOME 11 study
P. Pautier; N. Penel; I. Ray-Coquard; A. Italiano; E. Bompas; C. Delcambre; J.O. Bay; F. Bertucci; J. Delaye; C. Chevreau; D. Cupissol; B. Le Moal; J.C. Eymard; A. Thyss; N. Isambert; C. Guillemet; M. Rios; S. Piperno-Neumann; G. Chenuc; F. Duffaud
2017
Results of the phase Ib dose escalation study of MEN1611, a PI3K inhibitor, combined with trastuzumab (T) +/- fulvestrant (F) for HER2+/PIK3CA mutant (mut) advanced or metastatic (a/m) breast cancer (BC)
M. Piccart; R. Borrego; F. Duhoux; H.T. Arkenau; D. de Speville; H. Wildiers; M. Campone; D. Tosi; J. Garcia-Corbacho; B. Jimenez; E. de Romani; A.M. Wardley; P. Tassone; V. Boni; Y. Jerez; P.G. Aftimos; A. Hennequin; F. Amair-Pinedo; A.U.E. Pellacani; D.O. Laurent
2020 		10.1016/j.annonc.2020.08.449
Results of the Phase II randomized French trial PRODIGE 21 comparing sorafenib vs pravastatin vs sorafenib and pravastatin vs best supportive care for the palliative treatment of HCC in CHILD B cirrhotic patients
J.F. Blanc; F. Khemissa; J.P. Bronowicki; C. Monterymard; J.M. Perarnau; V. Bourgeois; S. Obled; M.B. Abdelghani; I. Mabile-Archambeaud; R. Faroux; J.F. Seitz; C. Locher; H. Senellart; A.L. Villing; F. Audemar; C. Costentin; G. Delplanque; S. Manfredi; J. Edeline
2018 		10.1016/S0168-8278(18)30601-9
Results of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC)
V. Westeel; F. Barlesi; P. Foucher; J.J. Lafitte; J. Domas; P. Girard; J. Tredaniel; M. Wislez; P. Dumont; E. Quoix; O. Raffy; D. Braun; M. Derollez; F. Goupil; J. Hermann; E. Devin; E. Pichon; J.P. Gury; F. Morin; P.J. Souquet
2017
Results of the prospective trial evaluating radiation-induced lymphocyte apoptosis and prostate RT
D. Azria; G. Crehange; F. Castan; E. Schwartz; Y. Belkacemi; J. Lagrange; T. Nguyen; O. Chapet; F. Mornex; G. Noel; E. Lartigau; D. Pasquier; S. Clippe; C. Hennequin; S. Gourgou; M. Brengues; P. Fenoglietto; M. Farcy-Jacquet; E. Ozsahin
2019 		10.1016/S0167-8140(19)30918-1
Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REG) in patients (pts) with metastatic relapsed Ewing sarcoma (ES), on behalf of the French Sarcoma Group (FSG) and UNICANCER
F. Duffaud; J.Y. Blay; O. Mir; C.M. Chevreau; B. Rouquette; E. Kalbacher; N. Penel; C. Perrin; V. Laurence; E. Bompas; E. Saada-Bouzid; C. Delcambre; F. Bertucci; M. Cancel; C. Schiffler; L. Monard; C. Bouvier; V. Vidal; N. Gaspar; S. Chabaud
2020 		10.1016/j.annonc.2020.08.2309
Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REGO) in patients (pts) with relapsed advanced or metastatic chordoma, on behalf of the French Sarcoma Group (FSG) and Unicancer
F. Duffaud; S. Chabaud; C.M. Chevreau; A. Italiano; C. Perrin; N. Isambert; S. Piperno-Neumann; E. Saada-Bouzid; F. Bertucci; D. Cupissol; E. Kalbacher; B. Narciso; C. Schiffler; deSousa Carvalho; L. Monard; C. Bouvier; V. Vidal; J.Y. Blay; O. Mir
2021 		10.1016/j.annonc.2021.08.2138
Results of the Second Phase of the GER-e-TEC Experiment concerning the Telemonitoring of Elderly Patients Affected by COVID-19 Disease to Detect the Exacerbation of Geriatric Syndromes
A.A. Zulfiqar; D.Noaga Dami Massimbo; M. Hajjam; B. Geny; S. Talha; J. Hajjam; S. Erve; A. Hajjam; E. Andres
2021 		10.3390/jpm11111117
Results of the Surgical Management of Acute Limb Ischemia in the Nonagenarians
A. Dubouis; M. Vernier-Mosca; S. Rinckenbach; L.Salomon Du Mont
2021 		10.1016/j.avsg.2020.05.073
Results of the VENUS study: Bevacizumab efficacy and safety in platinum-sensitive recurrent ovarian cancer (OC)-A real-life ambispective study.
I.Laure Ray-Coquard; J. Alexandre; F. Goldwasser; J.P. Spano; D. Berton-Rigaud; A.M. Savoye; M. Fabbro; F. Bazan; E. Kalbacher; N. Raban; C. Giraud; V. Pottier; F. Selle; A. Patsouris; C. Garnier-Tixidre; A.Mercier Blas; J. Provencal; F. Brocard; J. Berdougo-Tritz; V. Launay-Vacher
2019 		10.1200/JCO.2019.37.15_suppl.5540
Results of the ``GER-e-TEC'' Experiment Involving the Use of an Automated Platform to Detect the Exacerbation of Geriatric Syndromes
A.A. Zulfiqar; O. Vaudelle; M. Hajjam; B. Geny; S. Talha; D. Letourneau; J. Hajjam; S. Erve; A.Hajjam El Hassani; E. Andres
2020 		10.3390/jcm9123836
RESVEGA, a Nutraceutical Omega-3/Resveratrol Supplementation, Reduces Angiogenesis in a Preclinical Mouse Model of Choroidal Neovascularization
F. Courtaut; V. Aires; N. Acar; L. Bretillon; I.Chiara Guerrera; C. Chhuon; J.P.Pais de Barros; C. Olmiere; D. Delmas
2021 		10.3390/ijms222011023
Resveratrol Favors Adhesion and Biofilm Formation ofLacticaseibacillus paracasei subsp. paracaseiStrain ATCC334
J.Al Azzaz; A.Al Tarraf; A. Heumann; D.Da Silva Barreira; J. Laurent; A. Assifaoui; A. Rieu; J. Guzzo; P. Lapaquette
2020 		10.3390/ijms21155423
Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro
S. Pasquereau; Z. Nehme; S.Haidar Ahmad; F. Daouad; J. Van Assche; C. Wallet; C. Schwartz; O. Rohr; S. Morot-Bizot; G. Herbein
2021 		10.3390/v13020354

Pages